Return of Utility Altcoins: Injective (INJ) and DTX Exchange Lead Gains as SOL Price Slumps
Utility tokens have once again taken the lead. While meme coins are currently seen struggling, utility tokens are soaring massively in this session. Injective (INJ) and DTX Exchange (DTX) are leading this session with rapid ascents and huge ROIs.
Solana’s market movement has left investors and analysts shocked with the SOL price touching the $265 mark. Experts anticipate that Injective (INJ) and DTX Exchange are also set to explode like Solana!
SOL Price Prediction: Can Solana Hit $300 Before 2025?
November has been a record-breaking month for Solana, with DEX volumes surpassing $100 billion. Daily trading volume hit an all-time high of $7.14 billion on November 18, and the week ending November 17 saw $41.6 billion in activity, with the SOL price soaring massively.
This remarkable surge reflects Solana’s growing popularity among traders, analysts speculate this could just be the catalyst for SOL price to hit $300 before 2025. Despite a minor pullback of 29% in the 24-hour trading volume, Solana has remained at 35% in the past month.
At press time, SOL price stands at $237. With such a strong foundation, analysts believe Solana is on track to hit $300 by early 2025 as long as the broader market remains bullish.
Injective (INJ) Price Analysis: INJ Soars In This Bull Run
Injective (INJ) has seen a substantial rally since the end of last week. INJ turned bearish last Tuesday as sellers drove the price down by 4.99%. Selling pressure persisted on Wednesday as INJ dropped almost 5% to $23.24.
However, Injective (INJ) made a strong recovery on Thursday, rebounding from a low of $22.47 to register an increase of 7.75% and settle at $25.04. Sellers made another attempt to drive Injective (INJ) lower on Friday as it dropped to $23.97, but buyers mounted a recovery, and the price rose by just over 6% and settled at $26.57.
The weekend saw Injective (INJ) surge past the resistance at $27 on Saturday, rising to an intraday high of $29.44 before settling at $27.83. Sellers drove Injective (INJ) to a low of $25.57 on Sunday.
Injective (INJ) recovered from this level to register an increase of just over 2% and settle at $28.42. The current week began with sellers back in control, with the price dropping over 5% and settling at $26.90. INJ recovered during the current session and is up by 6.26%, trading at $29.30. Analysts predict further ascents for INJ tokens.
DTX Exchange (DTX): The Future Of Asset Trading Raises $8,700,000
DTX Exchange (DTX) isn’t a new entry in the crypto space; it’s a disruptive force ready to reshape the global trading industry. Sitting at the forefront of this revolution, DTX Exchange fuses the best aspects of centralized (CEX) and decentralized exchanges (DEX).
DTX is a proprietary hybrid Layer-1 blockchain-powered platform that enables seamless trading of over 120,000 asset classes such as stocks, bonds, ETFs, and cryptocurrencies. This proven versatility makes DTX a game changer in the $36B global trading market.
The hybrid platform’s token provides one-of-a-kind utility in the platform, discounted fees, staking rewards, and governance rights. DTX Exchange is currently offering tokens at an undervalued price, at $0.1 per token, during its fifth ICO round, raising over $8.78 million.
Having a potential 200x increase, some analysts predict that when DTX gets listed on tier-1 exchanges, a price tag of $20 is very reasonable. This means a $250 investment in this market cycle could lead to $50,000 by the end of March.
Key Takeaways
Injective (INJ) and DTX Exchange (DTX) are both expected to see enormous gains, just like Solana. Solana’s rally sparks excitement, and the SOL Price hits an all-time high! These altcoins follow Solana’s ideal price movements. Experts anticipate INJ and DTX to explode massively by 10x in this bull run!
Learn more:
Buy Presale Visit DTX Website Join The DTX Community
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tether invests $775 million in Rumble
Dogecoin drops over 30% from its yearly high of $0.48
Mo Shaikh steps down as CEO of Aptos Labs
MetaMask users can now stake EOS coins